Fifty-four months' experience with an improved tilting disk valve (Medtronic-Hall)

Area of Science:

• Cardiovascular Surgery
• Biomedical Engineering
• Prosthetic Devices

Background:

• Heart valve replacement is a critical procedure for patients with valvular heart disease.
• The Medtronic-Hall valve prosthesis is a mechanical device designed for valve replacement.
• Assessing the long-term safety and efficacy of prosthetic valves is essential.

Purpose of the Study:

• To evaluate the clinical outcomes and hemodynamic performance of the Medtronic-Hall valve prosthesis.
• To determine the complication rates, including thromboembolism and operative mortality, associated with this valve prosthesis.
• To assess the durability and functional characteristics of the Medtronic-Hall valve in aortic and mitral positions.

Main Methods:

• A retrospective study of 230 consecutive patients undergoing valve replacement (aortic, mitral, or double valve) with the Medtronic-Hall prosthesis between 1978 and 1982.
• Follow-up data were collected for 212 patients with a mean follow-up of 26.5 months.
• Incidence of thromboembolism, operative mortality, and freedom from complications were analyzed. Hemodynamic performance was assessed via recatheterization.

Main Results:

• Operative mortality was 7.8%.
• Thromboembolism rates were 1.2%/patient-year for aortic valve replacement (AVR) and 2.4%/patient-year for mitral valve replacement (MVR). No thromboembolism was observed after double valve replacement (DVR).
• Freedom from any complications was 80% at 3 years. Mean pressure gradients were low, indicating good hemodynamic function.

Conclusions:

• The Medtronic-Hall valve prosthesis serves as a durable and effective substitute for heart valve replacement.
• The prosthesis exhibits favorable hemodynamic performance with low complication rates, including thromboembolism.
• This study supports the Medtronic-Hall valve as a reliable option for both aortic and mitral valve replacement procedures.